Dabigatran vs. warfarin in relation to the presence of left ventricular hypertrophy in patients with atrial fibrillation: the Randomized Evaluation of Long-term anticoagulation therapY (RE-LY) study
AbstractAim. We tested the hypothesis that left ventricular hypertrophy (LVH) interferes with the antithrombotic effects of dabigatran and warfarin in patients
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
2018
|
| In: |
Europace
Year: 2017, Volume: 20, Issue: 2, Pages: 253-262 |
| ISSN: | 1532-2092 |
| DOI: | 10.1093/europace/eux022 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1093/europace/eux022 Verlag, lizenzpflichtig, Volltext: https://academic.oup.com/europace/article/20/2/253/3829706 
|
| Author Notes: | Paolo Verdecchia, Gianpaolo Reboldi, Fabio Angeli, Giovanni Mazzotta, Gregory Y.H. Lip, Martina Brueckmann, Eva Kleine, Lars Wallentin, Michael D. Ezekowitz, Salim Yusuf, Stuart J. Connolly, and Giuseppe Di Pasquale |
| Summary: | AbstractAim. We tested the hypothesis that left ventricular hypertrophy (LVH) interferes with the antithrombotic effects of dabigatran and warfarin in patients |
|---|---|
| Item Description: | Gesehen am 05.05.2020 Online publish-ahead-of-print 17 May 2017 |
| Physical Description: | Online Resource |
| ISSN: | 1532-2092 |
| DOI: | 10.1093/europace/eux022 |